Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

The impact of clozapine treatment on serum lipids in chronic schizophrenic patients.

Spivak B, Lamschtein C, Talmon Y, Guy N, Mester R, Feinberg I, Kotler M, Weizman A.

Clin Neuropharmacol. 1999 Mar-Apr;22(2):98-101.

PMID:
10202605
2.

Suicide in schizophrenia: risk factors and clozapine treatment.

Meltzer HY.

J Clin Psychiatry. 1998;59 Suppl 3:15-20. Review.

3.
4.

Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia.

Avnon M, Rabinowitz J.

Br J Psychiatry. 1995 Dec;167(6):760-4. Review.

PMID:
8829743
5.

Neuroleptic treatment of schizophrenia.

Lauriello J, Jeste DV.

Compr Ther. 1992 Jan;18(1):30-5. Review. No abstract available. Erratum in: Compr Ther 1992 Apr;18(4):39.

PMID:
1346590
6.

[Low concentration level of total serum cholesterol as a risk factor for suicidal and aggressive behavior].

Ainiyet J, Rybakowski J.

Psychiatr Pol. 1996 May-Jun;30(3):499-509. Review. Polish.

PMID:
8848510
7.

Differential effects of neuroleptic and clozapine on polydipsia and intermittent hyponatremia.

Leadbetter RA, Shutty MS Jr.

J Clin Psychiatry. 1994 Sep;55 Suppl B:110-3. Review.

PMID:
7961552
8.

Sexual behavior of the male schizophrenic: the impact of illness and medications.

Nestoros JN, Lehmann HE, Ban TA.

Arch Sex Behav. 1981 Oct;10(5):421-42. Review.

PMID:
6119066
9.

[The neurobiological bases of aggression: the pharmacotherapeutic implications].

De León OA.

Rev Med Panama. 1994 May;19(2):106-16. Review. Spanish.

PMID:
7991801
10.

Pharmacological management of persistent hostility and aggression in persons with schizophrenia spectrum disorders: a systematic review.

Victoroff J, Coburn K, Reeve A, Sampson S, Shillcutt S.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):283-312. doi: 10.1176/appi.neuropsych.13110335. Review.

PMID:
26037853

Supplemental Content

Support Center